Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PVAB Regimen for Elderly Patients with Classical Hodgkin Lymphoma
NCT02414568Phase 2Completed
- Sponsor
- LYSARC
- Start
- Jul 2015
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of bendamustine in classical Hodgkin lymphoma (cHL), sponsored by LYSARC. Started Jul 2015; status: completed.
02
Drugs
bendamustine
03
Conditions
classical Hodgkin lymphoma (cHL)
Beyond the preview
Go deeper on NCT02414568.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02414568.